Security Snapshot

Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) Institutional Ownership

CUSIP: 00404A109

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

294

Shares (Excl. Options)

132,476,547

Price

$23.39

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
+10,797,247
Value change
+$284,378,126
Number of holders
294
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
91,899,876
SEC-reported price per share
$27.15
Insider filing price
$27.15
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • ACHC - Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share is tracked under CUSIP 00404A109.
  • 294 institutions reported positions in Q1 2026.
  • 8 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 250 to 294 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $1,726,239,688 to $3,096,524,538.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 294 institutions filings for Q1 2026.

Open SEC evidence

Security key

00404A109

Latest holder period

Q1 2026

13F holders

294

13D/G owners

8

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
8
Security
ACHC
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 11% $217,941,727 10,348,610 BlackRock, Inc. 30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP 9.9% -22% $235,352,115 -$70,073,434 9,072,942 -23% Wellington Management Group LLP 31 Mar 2026
FMR LLC 6.7% $138,008,487 6,230,631 FMR LLC 31 Dec 2024
Khrom Investments Fund, LP 5.7% -30% $134,927,766 -$58,514,881 5,201,533 -30% Eric Khrom 31 Mar 2026
VANGUARD PORTFOLIO MANAGEMENT LLC 5.5% $118,810,979 5,079,563 Vanguard Portfolio Management 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.2% $113,175,719 4,838,637 Vanguard Capital Management 31 Mar 2026
GOLDMAN SACHS GROUP INC 1.6% -70% $37,979,421 -$84,132,758 1,464,126 -69% THE GOLDMAN SACHS GROUP, INC. 31 Mar 2026
T. Rowe Price Investment Management, Inc. 1% $21,032,953 949,569 T. Rowe Price Investment Management, Inc. 31 Mar 2025

As of 31 Mar 2026, 294 institutional investors reported holding 132,476,547 shares of Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC). This represents 144% of the company’s total 91,899,876 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
104%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 13% 11,686,389 +2.5% 0% $273,344,638
WELLINGTON MANAGEMENT GROUP LLP 9.9% 9,072,942 -23% 0.04% $212,216,113
FMR LLC 7.5% 6,867,678 +27% 0.01% $160,634,995
Khrom Capital Management LLC 5.7% 5,194,625 -29% 11% $121,502,279
VANGUARD PORTFOLIO MANAGEMENT LLC 5.5% 5,061,438 0% 0.01% $118,387,035
DEERFIELD MANAGEMENT COMPANY, L.P. 4.9% 4,520,000 0% 1.2% $105,722,800
DME Capital Management, LP 4.9% 4,518,381 +9.6% 3.3% $105,684,932
MORGAN STANLEY 4.9% 4,491,067 +194% 0.01% $105,046,060
ABRAMS BISON INVESTMENTS, LLC 4.8% 4,380,000 0% 4.4% $102,448,200
VANGUARD CAPITAL MANAGEMENT LLC 4.5% 4,154,801 0% 0% $97,180,795
Jefferies Financial Group Inc. 3.9% 3,611,883 +6.9% 1% $84,481,944
STATE STREET CORP 3.5% 3,218,751 -2.3% 0% $75,286,586
UBS Group AG 3.1% 2,833,862 +43% 0.01% $66,284,032
CITADEL ADVISORS LLC 3% 2,716,425 +100% 0.05% $63,537,181
DIMENSIONAL FUND ADVISORS LP 2.8% 2,581,747 -7.3% 0.01% $60,383,734
MAK CAPITAL ONE LLC 2.6% 2,432,962 9.4% $56,906,981
CITIGROUP INC 2.6% 2,352,318 -8.6% 0.04% $55,020,718
CARRONADE CAPITAL MANAGEMENT, LP 2.5% 2,337,236 4% $54,668,000
GOLDMAN SACHS GROUP INC 2.4% 2,240,428 -53% 0.01% $52,403,620
NEUBERGER BERMAN GROUP LLC 2.1% 1,961,384 +72% 0.03% $45,831,140
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 2.1% 1,900,947 +34% 0.01% $44,463,150
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. 2% 1,839,125 0.43% $43,017,134
P2 Capital Partners, LLC 1.9% 1,774,484 20% $41,505,181
FARALLON CAPITAL MANAGEMENT LLC 1.9% 1,736,800 0.26% $40,623,752
FIRST TRUST ADVISORS LP 1.8% 1,689,442 +73% 0.03% $39,515,959

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 132,476,547 $3,096,524,538 +$284,378,126 $23.39 294
2025 Q4 121,647,682 $1,726,239,688 +$3,927,608 $14.19 250
2025 Q3 113,557,143 $2,812,604,893 +$198,610,835 $24.76 267
2025 Q2 106,180,176 $2,409,474,221 +$103,570,855 $22.69 293
2025 Q1 100,196,553 $3,036,849,808 -$83,218,159 $30.32 291
2024 Q4 100,303,061 $3,977,210,670 -$244,355,396 $39.65 303
2024 Q3 98,277,466 $6,230,743,414 +$95,258,322 $63.41 307
2024 Q2 96,702,208 $6,530,554,819 +$227,034,398 $67.54 304
2024 Q1 93,239,072 $7,379,280,140 +$49,334,315 $79.22 316
2023 Q4 92,522,774 $7,193,575,118 +$61,021,151 $77.76 308
2023 Q3 91,495,056 $6,432,157,108 -$110,869,598 $70.31 290
2023 Q2 93,104,775 $7,413,877,644 +$21,836,683 $79.64 278
2023 Q1 92,851,264 $6,708,375,103 +$108,041,522 $72.25 305
2022 Q4 91,395,989 $7,523,912,097 -$147,206,889 $82.32 340
2022 Q3 93,271,335 $7,293,955,259 -$736,918,242 $78.18 310
2022 Q2 93,086,616 $6,296,378,261 +$218,949,542 $67.63 275
2022 Q1 90,403,601 $5,924,313,202 +$5,681,531 $65.53 282
2021 Q4 90,317,634 $5,481,351,744 -$5,797,419 $60.70 270
2021 Q3 90,244,441 $5,754,680,982 +$16,478,124 $63.78 287
2021 Q2 89,996,070 $5,646,410,777 -$40,751,033 $62.75 283
2021 Q1 90,677,699 $5,181,144,725 +$27,794,038 $57.14 266
2020 Q4 90,615,773 $4,553,661,692 -$105,569,972 $50.26 258
2020 Q3 92,936,171 $2,735,093,869 -$55,086,757 $29.48 217
2020 Q2 94,892,895 $2,383,686,906 -$51,470,812 $25.12 204
2020 Q1 97,651,901 $1,791,890,902 -$214,475,490 $18.35 202
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .